Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mesa LaboratoriesMLAB -0.16%76 Debt-to-Equity is 0.83 as of Mar. 2026, which is 48% above its 10-year median of 0.56. GuruFocus rates MLAB with a GF Score™ of 76/100 and a GF Value™ of $116.28 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 2,215 Hardware companies, Mesa Laboratories ranks worse than 81.04% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Mesa Laboratories's Debt-to-Equity or its related term are showing as below:
MLAB'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.2 Med: 0.56 Max: 1.55
Current: 0.83
During the past 13 years, the highest Debt-to-Equity Ratio of Mesa Laboratories was 1.55. The lowest was 0.20. And the median was 0.56.
MLAB's Debt-to-Equity is ranked worse than 81.04% of 2215
companies
in the Hardware industry
Industry Median: 0.27
vs MLAB: 0.83
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Mesa Laboratories Debt-to-Equity Related Terms
Mesa Laboratories Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Mesa Laboratories's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MLAB vs AERG, USBC, MVIS: Debt-to-Equity Comparison
For the Scientific & Technical Instruments subindustry, Mesa Laboratories's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mesa Laboratories Debt-to-Equity vs Hardware Industry
For the Hardware industry and Technology sector, Mesa Laboratories's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Mesa Laboratories's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mesa Laboratories (MLAB) has a Debt-to-Equity of 0.83 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Mesa Laboratories and its competitors. This is 48% above median its historical median of 0.56. Over the past decade, Mesa Laboratories' Debt-to-Equity has ranged from 0.20 to 1.55. According to the industry distribution chart, Mesa Laboratories ranks #1795 out of 2215 companies in the Hardware industry, placing it in the top 81%.
Is Mesa Laboratories' Debt-to-Equity too high?
Mesa Laboratories' current Debt-to-Equity of 0.83 is 48% above median its 10-year median of 0.56. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 1.55. The Hardware industry median Debt-to-Equity is 0.27. Mesa Laboratories' value of 0.83 is 207.4% above this industry median. Based on the distribution chart, Mesa Laboratories ranks #1795 out of 2215 companies in the Hardware industry, which is in the bottom quartile relative to peers. Overall, Mesa Laboratories has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mesa Laboratories' Debt-to-Equity compare to AERG and USBC?
According to the Hardware industry distribution chart, Mesa Laboratories ranks #1795 out of 2215 companies for Debt-to-Equity. This places Mesa Laboratories in the lower half of its industry. The industry median Debt-to-Equity is 0.27. Mesa Laboratories' value of 0.83 is 207.4% above this benchmark. Historically, Mesa Laboratories' own Debt-to-Equity has ranged from 0.20 to 1.55 over the past decade. While the company's 10-year median is 0.56 vs. the industry median of 0.27, Mesa Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Hardware company?
The median Debt-to-Equity among Hardware companies is 0.27, based on 2,215 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mesa Laboratories's current Debt-to-Equity of 0.83 is 207.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Mesa Laboratories and its competitors. For the Hardware industry, the median Debt-to-Equity is 0.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mesa Laboratories's current Debt-to-Equity is 0.83, which is 48% above median its own 10-year median of 0.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mesa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Mesa Laboratories (MLAB) is currently considered Modestly Undervalued. The stock's GF Value™ is $116.28, compared to a current price of $94.64 — trading 18.6% below its estimated fair value. The current Debt-to-Equity is 0.83, which is 48% above median its 10-year median of 0.56 and 207.4% above the Hardware industry median of 0.27. Mesa Laboratories' overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Mesa Laboratories (MLAB), the current Debt-to-Equity is 0.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mesa Laboratories (MLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Mesa Laboratories stock appears to be undervalued.
The current stock price of $94.64 is trading 18.6% below its estimated GF Value™ of $116.28.
GuruFocus considers Mesa Laboratories to be Modestly Undervalued.
Key valuation signals for MLAB:
Debt-to-Equity: 0.83 (48% above median its 10-year median of 0.56)
GF Value™: $116.28 vs. price of $94.64 (18.6% below fair value)
Industry Position: 207.4% above the Hardware median (#1795 of 2215)
No single metric tells the full story. See the MLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
76GF Score
Get the complete analysis for MLAB
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLAB has been successfully added to your 
